Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicardipine for Radial Artery Cannulation
NCT05920538Unknown
- Sponsor
- Mahidol University
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicardipine (2 arms), sponsored by Mahidol University. Primary endpoint: Success rate of radial artery cannulation since first skin puncture at 10 minutes. Status: unknown.
02
Drugs
nicardipine
Beyond the preview
Go deeper on NCT05920538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05920538.